Recursion Pharmaceuticals Inc (RXRX) Insider Trading
- $2,787,850.00
- $29,789,735.81
- May 1, 2024
- Christopher Gibson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 1, 2024 | CEO | 50,000 | $7.73 | Sell | $386,500.00 | |
April 30, 2024 | Director | 11,447 | $7.95 | Sell | $91,003.65 | |
April 25, 2024 | COO | 3,000 | $7.67 | Sell | $23,010.00 | |
April 17, 2024 | CFO | 23,124 | $7.58 | Sell | $175,279.92 | |
April 16, 2024 | Director | 11,447 | $7.66 | Sell | $87,684.02 | |
April 3, 2024 | CEO | 40,000 | $8.84 | Sell | $353,600.00 | |
April 2, 2024 | Director | 11,447 | $8.82 | Sell | $100,962.54 | |
March 28, 2024 | CEO | 40,000 | $10.10 | Sell | $404,000.00 | |
March 21, 2024 | COO | 8,000 | $10.75 | Sell | $86,000.00 | |
March 19, 2024 | Director | 20,054 | $10.79 | Sell | $216,382.66 | |
March 13, 2024 | CFO | 25,000 | $11.03 | Sell | $275,750.00 | |
March 6, 2024 | CEO | 36,319 | $11.86 | Sell | $430,743.34 | |
March 5, 2024 | Director | 20,054 | $12.06 | Sell | $241,851.24 | |
Feb. 22, 2024 | COO | 8,000 | $14.89 | Sell | $119,120.00 | |
Feb. 20, 2024 | Director | 20,054 | $12.32 | Sell | $247,065.28 | |
Feb. 13, 2024 | CFO | 25,000 | $9.86 | Sell | $246,500.00 | |
Feb. 7, 2024 | CEO | 48,272 | $9.22 | Sell | $445,067.84 | |
Feb. 6, 2024 | Director | 11,447 | $9.30 | Sell | $106,457.10 | |
Jan. 25, 2024 | COO | 8,000 | $10.35 | Sell | $82,800.00 | |
Jan. 23, 2024 | Director | 20,054 | $10.58 | Sell | $212,171.32 | |
Jan. 16, 2024 | CFO | 25,000 | $10.45 | Sell | $261,250.00 | |
Jan. 16, 2024 | Insider | 18,000 | $10.93 | Sell | $196,740.00 | |
Jan. 9, 2024 | Director | 29,000 | $13.66 | Sell | $396,140.00 | |
Jan. 3, 2024 | CEO | 30,853 | $9.49 | Sell | $292,794.97 | |
Dec. 26, 2023 | Director | 20,054 | $10.63 | Sell | $213,174.02 | |
Dec. 15, 2023 | Insider | 18,000 | $9.60 | Sell | $172,800.00 | |
Dec. 14, 2023 | Director | 20,141 | $9.00 | Sell | $181,269.00 | |
Dec. 12, 2023 | Director | 11,447 | $7.40 | Sell | $84,707.80 | |
Dec. 12, 2023 | CFO | 25,000 | $7.39 | Sell | $184,750.00 | |
Dec. 6, 2023 | CEO | 59,829 | $7.49 | Sell | $448,119.21 | |
Nov. 28, 2023 | Director | 11,447 | $6.72 | Sell | $76,923.84 | |
Nov. 16, 2023 | COO | 3,000 | $6.76 | Sell | $20,280.00 | |
Nov. 15, 2023 | Insider | 18,000 | $6.51 | Sell | $117,180.00 | |
Nov. 14, 2023 | Director | 8,885 | $6.32 | Sell | $56,153.20 | |
Nov. 14, 2023 | CFO | 25,000 | $6.32 | Sell | $158,000.00 | |
Nov. 1, 2023 | CEO | 37,177 | $5.20 | Sell | $193,320.40 | |
Oct. 31, 2023 | Director | 8,885 | $5.27 | Sell | $46,823.95 | |
Oct. 26, 2023 | COO | 3,000 | $5.63 | Sell | $16,890.00 | |
Oct. 17, 2023 | Director | 8,885 | $6.58 | Sell | $58,463.30 | |
Oct. 16, 2023 | Insider | 18,000 | $6.30 | Sell | $113,400.00 | |
Oct. 10, 2023 | CFO | 25,000 | $7.07 | Sell | $176,750.00 | |
Oct. 4, 2023 | CEO | 59,794 | $7.21 | Sell | $431,114.74 | |
Oct. 3, 2023 | Director | 8,885 | $7.29 | Sell | $64,771.65 | |
Sept. 28, 2023 | COO | 3,000 | $7.72 | Sell | $23,160.00 | |
Sept. 19, 2023 | Director | 8,885 | $8.36 | Sell | $74,278.60 | |
Sept. 15, 2023 | Insider | 18,000 | $8.66 | Sell | $155,880.00 | |
Sept. 13, 2023 | CFO | 25,000 | $8.69 | Sell | $217,250.00 | |
Sept. 6, 2023 | CEO | 33,765 | $8.78 | Sell | $296,456.70 | |
Sept. 5, 2023 | Director | 8,885 | $8.79 | Sell | $78,099.15 | |
Aug. 24, 2023 | COO | 3,000 | $8.66 | Sell | $25,980.00 |
Insiders are both buying and selling Recursion Pharmaceuticals Inc stock.
The insider traders at Recursion Pharmaceuticals Inc are: Christopher Gibson, Blake Borgeson, Tina Marriott Larson, Shafique Virani, Michael Secora, Mubadala Investment Co Pjsc, Tina Marriott, Dean Y Li, Gibson Christopher, Terry-Ann Burrell, and Zavain Dar
The most active insider trader at Recursion Pharmaceuticals Inc is Christopher Gibson with 41 trades.
Christopher Gibson has sold the most Recursion Pharmaceuticals Inc stock with a total value of $17,586,517.95.
Mubadala Investment Co Pjsc has bought the most Recursion Pharmaceuticals Inc stock with a total value of $3,191,575.00.
The most recent insider trade for Recursion Pharmaceuticals Inc was on May 1, 2024.
The single biggest insider buy for Recursion Pharmaceuticals Inc was from Mubadala Investment Co Pjsc with a total value of $730,795.32 on Feb. 21, 2023.
The single biggest insider sell for Recursion Pharmaceuticals Inc was from Christopher Gibson with a total value of $2,190,000.00 on March 7, 2022.